IFLR1000

Capital Group $200 million acquisition of 11% of Mankind Pharma

9/11/2015
Private acquisition
Select tab

$ 200 million

Completed

9/11/2015

Overview:

  • Capital International has acquired an 11% stake in Mankind Pharma, one of India’s leading pharmaceutical companies, for $200 million from ChrysCapital.
  • Mankind Pharma is India's seventh largest drug manufacturer.
  • Warburg Pincus was apparently also readying a bid for the company.

Katrin Kostadinova - Data analyst

Jurisdiction:

India

Deal type:

Private acquisition

Practice areas:

Private equity
M&A

Governing law:

India

Industry sector:

Pharmaceuticals and life sciences

Firms:
Debevoise & Plimpton

Party: Capital International (Acquirer)

Khaitan & Co

Party: Mankind Pharma (Target)

Related deals